Posted inNews and Updates
Brain-Computer Interface Restores Speech for Paralyzed Man
A groundbreaking brain-computer interface has restored natural speech for a paralyzed patient, marking a major leap in neurotechnology and medical care.
Posted inNews and Updates
Leqembi Study: 75% of Early Alzheimer’s Patients Stable
New LEADER study data reveals that 75% of early Alzheimer's patients on Leqembi remained stable, with some showing improvement after 17 months of treatment.
Posted inNews and Updates
Diranersen Shows Promise in Phase 2 Alzheimer’s Trial
New Phase 2 data for diranersen shows significant tau reduction in early Alzheimer's patients. Explore the clinical impact and future of this ASO therapy.
Posted inNews and Updates
New Bifidobacterium Oral Vaccine Boosts Anti-Tumor Immunity
Researchers report that a new Bifidobacterium-based oral vaccine successfully boosts anti-tumor immunity by activating CD8+ T-cells against cancer cells.
Posted inNews and Updates
Clinical Trial Recruitment Stalls Due to Site Inefficiencies
Over 50% of clinical trial sites are facing major recruitment delays. Discover how operational inefficiencies are stalling drug development timelines today.
Posted inNews and Updates
Skyhawk Expands Huntington’s Disease Trial for SKY-0515
Skyhawk Therapeutics expands the FALCON-HD trial for SKY-0515 to the US, Canada, and UK, targeting the root cause of Huntington’s disease via RNA modulation.
Posted inNews and Updates
Psilocybin Therapy: Why FDA Progress Still Faces Hurdles
Despite successful Phase 3 trials and new FDA guidance, psilocybin therapy faces adoption hurdles. Explore the clinical and scaling challenges ahead.
Posted inNews and Updates
FDA Clears ATR-1072 for PRKAG2 Syndrome Clinical Trials
The FDA has cleared an IND application for ATR-1072, a novel treatment for PRKAG2 syndrome. Learn about this breakthrough in genetic cardiac therapy.
Posted inNews and Updates
New Cancer Drug Shows Promise in Mesothelioma Trial
A new clinical trial for a novel mesothelioma drug shows promising results. Learn how this targeted therapy could improve survival for lung cancer patients.
Posted inNews and Updates
AI Revolution: Transforming Clinical Trial Financial Models
Discover how AI is revolutionizing clinical trial finance by optimizing budgets, reducing risk, and accelerating medical research through predictive data.